FAQ

What profiles are recommended to identify cytotoxic substances and drugs against the disease?

Onconomics Plus or Onconomics

What profiles are recommended to monitor and monitor the patient

Oncocount RGCC or Oncotrace RGCC or Oncotrail RGCC (For known and specific types of malignant neoplasms only)

What is the time interval for using follow-up profiles

For the first year every quarter and then every semester

Which profiles on the state of the immune system and immunity?

Immune-Frame

Can CTCs (Circulating Tumor Cells) predict the site of recurrence and metastases?

For a period of three years, a meta-analysis was performed comparing the CTC profile and metastasis profile to detect potent markers that are relevant to the relapse site. The Metastat profile provides this information.

Which test focuses on the efficacy of therapeutic agents against a patient's cancer

ChemoSNip

What techniques have ben used to overcome the known difficulties of succescfully culturing chondrosarcoma cells from a blood test given that the tumor has no metastasis?

Migration of the primary tumor occurs relatively early during tumor progression. Almost less than 2mm in diameter of the primary tumor already spreads in newly formed vessels and cells that perform EMT are migrated through them into the circulation.

In the case of a man aged 62 years, with prostate enlargement without possibility of biopsy, what would be the tools for disgnosis, guidance and possible follow-up? What are the crucial markers?

Oncotrace R.G.C.C. to guide diagnosis and R.G.C.C. Oncotrail Prostate, for monitoring focused on PSMA and PSA markers.

Is it possible to determine through blood test whether a person is resistant or sensitive to a specific blood-based chemotherapeutic agent?

The isolation of CTCs can be performed with screening methods based on Flow Cytometry and avoid any noise caused by irrelevant cells. The assessment of CTCs may reveal sensitivity and resistance to various factors at the cellular level. The application to all organisms requires the cooperation and expertise of an oncologist with a high level of knowledge of pharmacology (Pharmacodynamics and Pharmacokinetics) in order to schedule doses, schedule and cycles at the patient level.

Do we use formulations and specialize products not listed in the RGCC Can we send samples to test these substances? These are also tested in combination ad many patients take more than one thing at a time?

In addition to cytotoxic drugs, monoclonal antibodies or small inhibitory molecules such as TKIs tyrosine kinase, we can test other substances via a viability / cytotoxicity assay and as induction of the immune response or as inhibitors of growth factor receptors. You can introduce us and send to our facilities any substance you deem appropriate. If you prefer to test them in combination we can offer this too, but it is up to the doctor to specify the combination, the time of each component and the proportion. Note: The sending and other costs to carry out this procedure will be the responsibility of the patient or doctor in charge.